While treatment of people with unhealthy weight has typically focused on patients with obesity, evidence indicates that the detrimental effects of excess weight on morbidity and mortality begin at lower BMI categories. Therefore, identifying at-risk patients who have overweight (BMI from 25.0 to <30.0 kg/m2) and initiating treatment earlier may interrupt the progression toward further weight gain and the development of obesity-related comorbidities. The first step in treatment is broaching the topic of weight with the patient in an empathic and respectful manner. All patients should be provided guidance on following a calorie-controlled healthy diet and engaging in daily physical activity. For some patients, prescription of a medication approved for weight loss may be warranted after reviewing the risks and benefits of the available agents. With the FDA clearance of 2 nonprocedural devices, we now have additional therapeutic options for patients who have a lower BMI, with evidence of modest weight loss and good patient tolerability.
|Original language||English (US)|
|Journal||Journal of Family Practice|
|State||Published - Sep 1 2020|
ASJC Scopus subject areas